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ABSTRACT
Phenolic bioactives from plant-based
foods have significant antioxidative and
associated
medicinal
and
therapeutic
properties and can be targeted against
oxidative stress-linked chronic diseases such
as type 2 diabetes (T2D). Legumes with
phenolic antioxidant-linked human health
function has both agro-ecological and public
health benefits. Since phenolic bioactives vary
among diverse genotypes, the major aim of
this study was to screen and investigate the
phenolic
antioxidant-linked
antihyperglycemic functionality of snap bean
(Phaseolus vulgaris) genotypes as dietary and
potential therapeutic target against early
stages of T2D. The aqueous extracts of 5
genotypes of commonly consumed green snap
bean pods grown separately under field and
greenhouse conditions were investigated for
total soluble phenolic content (TSP), phenolic
acid profile, total antioxidant (TA) activity, αamylase, and α-glucosidase enzyme inhibitory

activities using in vitro assay models. Among
genotypes, OR 5630 had moderate TSP
content, moderate to high TA activity, and
high α-amylase enzyme inhibitory activity,
while moderate α-glucosidase enzyme
inhibitory activity was observed in Ebro and
Eagle genotypes both in the field and
greenhouse grown pods. Therefore, the
genotypes
with
moderate
phenolic
antioxidant-linked
antihyperglycemic
properties can be further investigated in vivo
studies with animal models to integrate with
healthy dietary intervention strategies or for
potential
therapeutic
and
medicinal
applications against early stages of T2D and
its associated complications.
INTRODUCTION
Diverse biological functions of secondary
metabolites, such as phenolic bioactives in food
crops provide multiple opportunities to utilize
them for medicinally relevant human health
applications including in dietary and potential
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therapeutic strategies against non-communicable
chronic diseases (NCDs). Although human cells
cannot
produce
phenolic
antioxidants
themselves, dietary consumption of these
phenolic bioactives or targeting them for
therapeutic strategies from plant-based sources
has diverse health benefits, especially against
chronic oxidative stress-linked NCDs, such as
T2D (Kahn et al., 2014; Pandey and Rizvi, 2009).
Phenolic antioxidants of plant-based foods can
either directly offset cellular damages caused by
reactive oxygen species (ROS) (Rice-Evans et
al., 1997) or can induce endogenous antioxidant
enzyme responses when consumed as a part of
the diet or targeted in therapeutic and medicinal
applications (Shetty and Wahlqvist, 2004).
Animal cells including human cells typically
respond to these phenolic bioactives mainly
through direct interactions with receptors or
enzymes involved in metabolic processes of
digestion, signal transduction, or through
modifying gene expressions which may result
from modification of the redox status of the cell
induced from a series of redox- dependent
reactions (Shalaby and Horwitz, 2015; Tsao and
Rong, 2010). Therefore, when consumed or
targeted in therapeutic and medicinally relevant
strategies, phenolic bioactives can help in
maintaining redox homeostasis by countering
ROS-induced chronic oxidative stresses, which
are commonly associated with hyperglycemia
linked to T2D (Rochette et al., 2014). Beyond
such specific bioactive role as a redox regulator,
there are strong evidences of other important
protective health relevant benefits of phenolic
antioxidants of food crops modulating and
inhibiting key disease pathways (Sarkar and
Shetty, 2014; Shetty and Wahlqvist, 2004).
Numerous such protective functions of
phenolic bioactives are associated with cardioprotection, anti-cancer, anti-aging, neuroprotection,
and
anti-diabetes
benefits
(Fernandez-Panchon et al., 2008; Pandey and
Rizvi, 2009; Shahidi and Ambigaipalan, 2015).
Phenolic bioactives and their metabolites also
influence digestion, absorption, and metabolism

of dietary carbohydrates (such as starch and
sucrose), which has direct implications for T2D
management (Hanhineva et al., 2010; McCue
and Shetty, 2004). Specifically, phenolic
bioactives from cereal grains, legumes,
vegetables, and fruits potentially influence
glucose metabolism in part by inhibiting αamylase, and α-glucosidase enzyme activities,
which are key digestive enzymes responsible for
carbohydrate digestion and glucose absorption
in the small intestine (Hanhineva et al., 2010;
McCue and Shetty, 2004). Inhibition of these
digestive enzymes could reduce the rate of
glucose release and absorption in the small
intestine
and
subsequently
suppress
postprandial hyperglycemia and therefore,
dietary phenolics are excellent diet-based
therapeutic targets to manage early stages of
T2D (Hanhineva et al., 2010; Sarkar and Shetty,
2014). Previous in vitro studies have reported
that phenolic bioactives of food crops, including
legumes posses significant α-amylase and αglucosidase enzyme inhibitory activities and can
be targeted in dietary and therapeutic strategies
to manage early stages of T2D (Hanhineva et al.,
2010, Kwon et al., 2007; Ranilla et al., 2009;
Singhal et al., 2014). Apart from this specific
digestive role in improving glucose metabolism,
legumes are also considered as an important
antidote for preventing and managing T2Dlinked cardiovascular diseases (Jukanti et al.,
2017).
Most edible legumes also have a higher
amount of resistant starch and amylose in the
seeds which are resistant to rapid digestion in
the small intestine and ultimately resulting in
lower availability of glucose (Jukanti et al.,
2017). The lower bioavailability coupled with
slower entry of glucose in the bloodstream
reduce the demand for insulin and thus lower the
glycemic index and insulinemic postprandial
response (Jukanti et al., 2017). In addition,
legumes including common green beans and
peas are also high in soluble and insoluble fiber,
low in sodium and fat, and are an excellent
source of complex carbohydrates, B vitamins,
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folate, and minerals such as calcium, iron,
magnesium and potassium (Roy et al., 2010).
Fresh green beans including snap beans contain
quercetin and kaempferol classes of phenolics
and fresh pods have more complex phenolic
profile compared to seeds (Escarpa and
González, 2000). Higher anti- hyperglycemic
properties and improvement in collagen
accumulation was observed in in vivo animal
model studies with green bean pod extracts (Pari
and Venkateswaran, 2003; Roman-Ramos et al.,
1995). Howvever, such human health relevant
phenolic bioactive profiles of common snap
beans vary significantly with cultivation and
growing conditions, genotypes, and with other
phenotypic traits (Kleintop et al., 2016).
Although higher consumption of easy to use
fresh snap bean has been encouraged due to
diverse potential human health benefits,
however a gap exists in biochemical rationalebased evidences for phenolic antioxidant-linked
anti-hyperglycemic properties of specific snap
bean genotypes and based on their different
growing conditions that can be targeted for
medicinally relevant health benefits. Therefore,
the major aim of this study was to develop a
strategy to screen different snap bean genotypes
for
their
phenolic
antioxidant-linked
antihyperglycemic properties using rapid in
vitro assay models and comparing between field
and greenhouse grown snap bean pods as a
biochemical rationale-based foundation for
further long-term dietary and therapeutic
applications as well as basis for further crop
breeding strategies.
MATERIALS AND METHODS
Materials. In this study, green pods of 5
different genotypes of snap beans (Phaseolus
vulgaris L.) (Bogota, Eagle, Ebro, Oregon 5630,
and Tendergreen) were evaluated. Selection of
these snap bean genotypes was based on their
genetic diversity and common use of these
genotypes in the market. Green pods of these
snap bean genotypes were obtained from the
Oregon State University, Corvallis, USA, in

2014 (from Bean CAP Snap Bean Diversity
Panel) and frozen snap bean samples were
analyzed at North Dakota State University,
Fargo, ND, USA. All 5 snap bean genotypes
evaluated in this study were planted and grown
(crop year 2014) in field plots at the Oregon
State University Vegetable Research Farm,
Corvallis, Oregon. The soil type of the vegetable
research farm is Chehails silty clay loam soil
and located at latitude N44.571209, longitude
W123.243261 at 77 m.a.s.l. The site is
continuously planted with snap bean over the
years and randomized complete block design
was used. All standard field practices were used
to plant, grow, and harvest snap beans (Kleintop
et al., 2016). After harvest snap beans pods were
immediately frozen and transported to North
Dakota State University for biochemical
analyses.
In a separate experiment, snap been
seeds collected from Oregon State University,
Corvallis, USA were grown in the greenhouse
(AES Research Complex Greenhouse, North
Dakota State University, Fargo, ND, USA) in
2015. Snap bean plants were grown in 15 cm
diameter pots using professional grade potting
mix. The greenhouse temperature was kept
constant between 25 and 26°C. A photoperiod
of 14 h light and 10 h dark was used, and
beneficial nematodes (weekly application) were
used to minimize thrips and other insect
infestation in the greenhouse. Each genotype
was planted in eight pots and used as biological
replicates. After harvest, pods were transferred
to the laboratory and were frozen immediately
before extraction. Prior to cold-water extraction,
all pods were washed with distilled water and
excess water was soaked and blotted out using
paper towel. The chemical reagents used for
biochemical analysis were porcine pancreatic αamylase, starch, equivalent of intestinal αglucosidase from yeast (Saccharomyces
cerevisiae),
p-nitrophenyl-α-Dglucopyranoside (pNPG) and ABTS+ radical
cation-decolorization agent. All chemicals were
purchased from Sigma Chemical Co. (St. Louis,
MO, USA).
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Sample Extraction. Pod samples were
cut into small pieces and weighed. Green snap
bean pods of each genotype were extracted
separately using distilled water at a ratio of 20 g
of the sample (pod) per 50 mL of distilled water.
All samples were homogenized for 10 minutes
using a Waring blender. The samples were later
centrifuged at 10,015 g for two times with 20
min each. The supernatant was collected and
stored at 2°C in refrigerator during the study
period. Only aqueous extracts were targeted, as
these are the most relevant for physiological and
metabolic function in terms of digestion and
anti-hyperglycemic functional properties.
Total Soluble Phenolic Content. Total
soluble phenolic content of snap bean aqueous
extract was determined by a method described
by Shetty et al. (Shetty et al., 1995). In brief, 0.5
mL of the sample was transferred to a test tube
and mixed with 0.5 mL of water, 1 mL of 95%
ethanol and 5 mL of distilled water. To each
sample, 0.5 mL of 50% (v / v) Folin-Ciocalteau
reagent was added and mixed. After 5 min, 1 mL
of 5% Na2CO3 was added and mixed and then
kept in the dark for 60 min incubation. After 60
min incubation the absorbance of the sample
was read at 725 nm using UV/VIS
spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA). The absorbance values
were converted into total soluble phenolic
content and expressed in micrograms per gram
of fresh weight (FW). Standard curves were
established using various concentrations of
gallic acid in 95% ethanol.
Antioxidant Activity by ABTS [2, 2'azinobis(3-ethylbenzothiazoline-6-sulfonic
acid)]Free Radical Scavenging Assay. Total
antioxidant activity of aqueous extract of snap
bean pods was determined by the ABTS + free
radical cation scavenging assay (Re et al.,
1999). ABTS (Sigma Chemical Co. St. Louis,
MO) reagent was dissolved in water to a
concentration of 7 mM. Then ABTS stock
solution was prepared using 5 mL of 7 mM
ABTS with 88 µL of 140 mM potassium
persulfate. The mixture was allowed to stand in

the dark at room temperature for 12-16 h prior
to use in the assay. Before being added to the
sample, the stock solution was diluted with
ethanol (95%) in the ratio 1:88 to obtain an
absorbance of 0.70 ± 0.02 at 734 nm and was
equilibrated at 30°C. One milliliter of the ABTS
solution was then added to glass tubes
containing 50 µL of sample extract and then
mixed using vortex for 30 sec. After 2.5 min of
incubation, the absorbance of the mixture was
read
at
734
nm
using
UV/VIS
spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA). The readings were
compared with controls, which contained 50 µL
of 95% ethanol instead of aqueous extract of
snap bean green pods. The Trolox reference
standard for relative antioxidant activities was
prepared with 5 mM stock solution of Trolox in
ethanol. Percent inhibition was calculated by:

α-Amylase Inhibitory Activity Assay.
Porcine pancreatic α-amylase was purchased
from Sigma Chemical Co (St. Louis, MO,
USA). A volume of 500 µL of supernatant and
500 µL of 0.02 M sodium phosphate buffer (pH
6.9 with 0.006 M sodium chloride) containing
α-amylase enzyme solution (0.5 mg.mL-1) was
incubated at 25ºC for 10 min. After preincubation, 500 µL of a 1% starch solution in
sodium phosphate buffer 0.02 M (pH 6.9 with
0.006 M NaCl) was added to each test tube at
timed intervals (Kwon et al., 2007). The
reaction mixtures were then incubated at 25ºC
for 10 min. The reaction was stopped by adding
1.0 mL of 3, 5-dinitro salicylic acid (DNS) color
reagent. The test tubes were then incubated in a
water bath with boiling water (90-100 ºC) for 10
min and later cooled at room temperature. The
reaction mixture was then diluted upon addition
of 10 mL of distilled water and the absorbance
of the sample was measured at 540 nm using
UV/VIS spectrophotometer (Thermo Fisher
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Scientific, Waltham, MA, USA). Percent
inhibition was calculated as follows:

α-Glucosidase Enzyme Inhibitory Activity
Assay. α-Glucosidase assay was performed
using 50 µL of the supernatant and 100 µL of
0.1 M phosphate buffer (pH 6.9) containing αglucosidase solution (1.0 U.mL-1) and
incubated in 96-well plates at 25°C for 10 min
(Kwon et al., 2007). After pre-incubation, 50
µL of a solution of 5 mM p-nitrophenyl-α-Dglucopyranoside in 0.1 M phosphate buffer
(pH 6.9) was added to each well at time
intervals. The reaction mixtures were then
incubated at 25°C for 5 min. Before and after
incubation, the absorbance readings were
recorded at 405 nm by a microplate reader
(Thermomax, Molecular Device Co.,
Virginia, USA) and compared with a control,
which contained 50 µL of buffer instead of
aqueous extract of pods. The inhibitory
activity of α- glucosidase was expressed as %
inhibition and calculated as follows:

temperature, with a total run time of 25 min.
Pure standards of gallic acid, catechin,
chlorogenic acid, ferullic acid, quercetin, pcoumaric acid, and kaemferol in 100% methanol
were used to calibrate retention times on the
standard curve. The chromatograms so obtained
were analyzed using the Agilent Chemstation
integration software.
Statistical
Analysis.
The
entire
laboratory based biochemical (in vitro) and
bioactive analysis was repeated four times from
same snap bean sample obtained from Oregon
State University from crop year 2014 and also
from the greenhouse experiment at North
Dakota State University in 2015. The analysis of
each experiment were performed in triplicates.
The means and standard deviations were
calculated from the replicates of the
experiments and analysis were performed using
Microsoft Excel XP. Data were subjected to
analysis of variance (ANOVA) to determine the
significant differences between treatments.
Significant differences were analyzed using
Tukey test (P<0.05) by the R program (www.rproject.org).

RESULTS
Phenolic Acid Profile Determination
Using
High
Performance
Liquid
Chromatography (HPLC). Green pod sample
extracts of snap beans were micro- centrifuged
for 10 min at 13,000 rpm, from which a small
volume (5 µL) of the sample was subjected to
chromatographic analysis using reverse phase
HPLC (Agilent 1260 Infinity Series equipped
with DAD 1100 diode array detector; Agilent
Technologies, Palo Alto, CA). A gradient
elution method, involving 10 mM phosphoric
acid (pH 2.5; Solvent A) and 100% methanol
(Solvent B), was used. Sample extracts were
eluted on a C-18 analytical column (Agilent
Supelco SB-C18 250 × 4.6 mm internal
diameter) with a packing material particle size
of 5 µm, at a flow rate of 0.7 mL/min at ambient

Total Soluble Phenolic (TSP) Content
and Total Antioxidant (TA) Activity. Total
soluble phenolic (TSP) content and total
antioxidant (TA) activity of snap bean
genotypes from field and greenhouse were
determined. Statistically significant variations
in TSP content and TA activity was observed
between snap bean genotypes (p<0.05) (Figure
1 A, B & 2 A, B).
The TSP content of aqueous extracts of
snap bean pods ranged from 197.9 to 330.5
(µgGAE. g-1 FW) in field grown pods (Figure
1A) and 127.8 to 322.4 (µgGAE. g-1 FW) in
greenhouse grown pods. In the field grown pods,
highest TSP content was found in Tendergreen
followed by OR 5630 (Figure 1A). Interestingly,
when grown under greenhouse condition
24
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Tendergreen had lowest TSP content, while OR
5630 had higher TSP content (Figure 1B). The
variation of TSP content in Tendergreen might
be due to the different growing condition
(between field and greenhouse) or due to some
other environmental factors.

In the greenhouse experiment higher TA activity
was observed in Ebro snap bean genotype
followed by OR 5630, Bogota, and Eagle
(Figure 2B). Like TSP content, lower TA
activity was observed in Tendergreen snap bean
genotype grown under greenhouse conditions
(Figure 2B).

The TA activity of 5 snap bean genotypes varied
significantly (p<0.05) and ranged from 32.6 to
79.3% (ABTS % inhibition) in pods grown
under field condition (Figure 2A) while 43.0 to
89.6 % (ABTS % inhibition) in snap beans
grown under greenhouse condition (Figure 2B).
Similar to the TSP content, Tendergreen snap
bean genotype had significantly higher (p<0.05)
TA activity followed by Ebro, OR 5630, Eagle,
and Bogota from field experiment (Figure 2A).

α-Amylase
and
α-Glucosidase
Inhibitory Activity. In this study, significant
differences in α-amylase inhibitory activity was
observed among 5 snap bean genotypes
(p<0.05) (Figure 3A, B). Alpha-amylase
enzyme inhibitory activity of aqueous pod
extracts of snap bean genotypes grown under
field condition was ranged from 43.9 to 83.6 (%
inhibition) (Figure 3A), while it was ranged
between 26 to 80 (% inhibition) in snap bean
25
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pods grown under greenhouse condition (Figure
3B). Among snap bean genotypes OR 5630 and
Bogota had higher α- amylase enzyme
inhibitory activity when compared to Eagle and
Ebro. Similar to TSP content and TA activity, αamylase inhibitory activity of Tendergreen snap
bean genotype varied significantly between
field and greenhouse experiments.

Inhibitory potentials of snap bean genotypes
against another key digestive enzyme, αglucosidase was also evaluated using in vitro
assay model. Significant dose dependent response
(undiluted, half-diluted, and one-fifth diluted) in
α- glucosidase inhibitory activity was observed in

all 5 snap bean genotypes in both field and
greenhouse grown pods (Table 1). In undiluted
sample, α-glucosidase enzyme inhibitory activity
of snap bean genotypes from field experiment
ranged from 24.9 to 50.5 (% inhibition), while it
ranged between 26.4 to 52.6 (% inhibition) in
greenhouse grown pods. Among snap bean
genotypes Eagle and Ebro had higher αglucosidase enzyme inhibitory activity at all
doses when compared with other 3 snap bean
genotypes and under both greenhouse and field
conditions (Table 1). Overall low to moderate αglucosidase enzyme inhibitory activity was
observed in this study.

Phenolic Acids Profile. Individual
phenolic acids of 5 snap bean genotypes were
determined using HPLC method. Major
phenolic acids detected in this study were
quercetin, catechin, and gallic acid (Table 2).
Previous studies have detected quercetin,
kaempferol, rutin, catechin and epicatechin as
major phenolic acids in green pods of green
bean cultivars (Abu-Reidah et al. 2013; Escarpa
and González, 2000). Use of different solvent,
extraction types, and HPLC protocol used in this
study may have contributed for detecting only 3
phenolic acids in snap bean genotypes. Similar
to TSP content higher concentrations of
individual phenolic acid, especially quercetin
was also observed in Tendergreen snap bean
26
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genotype grown under field condition when
compared to others (Table 2).
DISCUSSION
Since secondary metabolites, such as
phenolic bioactives of food crops have
relevance in cellular redox-regulation it can also
translate into therapeutic and medicinal
properties and human health benefits for
managing oxidation breakdown-linked NCDs,
such as T2D. Therefore, targeting food crops
with higher phenolic antioxidant profile for
therapeutic applications against oxidativestress linked T2D has sound rationale. However,
phenolic bioactive profiles and associated
human health benefits of food crops including
snap beans targeted in this study vary
significantly among genotypes, different
growing conditions (environment), and between
genotype × phenotype × environment
interactions (Kleintop et al., 2016).

Therefore, rapid in vitro screening of
different genotypes of snap beans for human
health relevant phenolic antioxidant profile and
associated functionalities targeting chronic
diseases has significant merit for further
development of superior varieties and wider use
for medicinal and therapeutic applications.
Based on this context and biochemical rationale,
5 different snap bean genotypes both from field

(one year) and greenhouse experiments were
evaluated and screened for phenolic
antioxidant-linked
antihyperglycemic
functionality targeting early stages of T2D using
rapid in vitro assay models. This provides the
biochemical-based rationale and foundation for
further development of targeted varieties for
wider health targeted applications.
Overall, moderate level (127.8 to 330
µgGAE. g-1 FW) of TSP content was found in
all 5 snap bean genotypes targeted in this study
and grown under field and greenhouse
conditions, which has relevance for diverse
human health benefits of phenolic bioactives
including their antioxidant-linked antihyperglycemic functionality that was evaluated
subsequently in this study. Baardseth et al.
(Baardseth et al., 2010) previously reported
similar range of TSP content in other green bean
genotypes (221 µgGAE. g-1 FW ). Although
Kleintop et al. (2016) also reported significantly
higher TSP content (1.01 mgGAE. g-1 FW) in
Tendergreen, the level of TSP content of OR
5630 reported by the same study was similar to
the finding in this study. The higher level of TSP
content in Tendergreen in earlier study might be
due to the use of different solvents (acetone
based extract), and extraction protocols, or due
to the differences in crop year (crop year 2010),
as growing conditions and environment could
have significantly contributed to the higher level
of TSP in Tendergreen (Kleintop et al., 2016).
The level of TA activity of snap bean genotypes
observed in this study was significantly higher
than what another study reported previously
(Gomes et al., 2009). Overall, moderate TSP
content and moderate to high TA activity of
snap bean genotype (OR5630) grown under
both field and greenhouse conditions found in
this study could potentially have significant
relevance for potential therapeutic applications
against chronic oxidative stress associated with
T2D and other NCDs.
Previously, the anti-hyperlipidemic and
antioxidant activity in aqueous extract of dried
green beans was reported (Venkateswaran and
27
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Pari, 2002). The anti- hyperlipidemic effect of
this previous study was targeted for reduction in
blood glucose level, triglycerides, free fatty
acids, phospholipids and total cholesterol when
bean extracts were administered in diabetesinduced rats (Venkateswaran and Pari, 2002).
The pathogenesis of T2D typically involves
increase of free radicals in the body coupled
with the deficiency of antioxidant protection and
further chronic oxidative stress from free
radicals that are formed disproportionately by
higher glucose oxidation, glycation of nonenzymatic proteins and subsequent oxidative
degradation of glycosylated proteins (Ceriello,
2000; Maritim et al., 2003). However, food
crops such as snap beans with moderate level of
phenolic bioactive-linked antioxidant capacity
have potential to provide protection against such
chronic oxidative stresses and therefore, can be
targeted for the medicinally relevant dietary and
therapeutic applications against oxidationlinked chronic inflammation commonly
associated with early stages T2D. Furthermore,
inhibition of digestive enzymes, such as αamylase and α- glucosidase with non-synthetic
and natural plant based sources is a safe
therapeutic strategy to prevent and manage
chronic hyperglycemia linked to early stages
T2D (Hanhineva et al., 2010; Kwon et al.,
2007). In addition, a 45-75% α-amylase
inhibitory activity was reported in beans
previously (Melzig and Funke, 2007). The role
of α- amylase in glucose metabolism is related
to its ability for catalyzing the hydrolysis of α1,4 glycosidic bond of starch, glycogen, and
other oligosaccharides which results in the rapid
release of simple sugars in the intestine (Ali et
al, 2006; Pereira et al., 2010). However, the
inhibition of this enzyme in the human digestive
tract
helps
to
manage
postprandial
hyperglycemia by slowing down the breakdown
of starch and other complex carbohydrates
(Negri and Negri, 2005). Overall, moderate to
high α-amylase enzyme inhibitory activity was
observed in all 5 snap bean genotypes in this
study, and therefore these genotypes can be
targeted in medicinally relevant therapeutic

strategies to manage hyperglycemia-linked to
T2D.
Managing postprandial hyperglycemia
is critical for overall management of T2D
(Baron,
1998).
Therefore,
controlling
postprandial glucose level in the blood is of
utmost importance in the treatment of T2D and
its associated macro and micro-vascular
complications (Ali et al., 2006; Subramanian et
al., 2008). Thus, several synthetic and nonsynthetic natural sources that have potential to
inhibit α- amylase and α-glucosidase were
evaluated and then targeted to design
pharmaceutical drugs for T2D treatments
(Kobayashi et al., 2000). However, synthetic
inhibitors can cause significant side effects,
some of which may increase the incidence of
renal tumors, can cause liver damage, and acute
hepatitis (Carascosa et al., 1997; Charpentier et
al., 2000). Therefore, finding non-synthetic
natural sources with moderate to high α-amylase
and α-glucosidase has significant relevance for
long-term and safe management of T2D using
therapeutic strategies. In this context snap bean
genotypes such as OR5630, Ebro, and Eagle can
be targeted and integrated in medicinally
relevant diets or in therapeutic strategies to
control hyperglycemia-linked to early stages of
T2D.
The health relevant benefits of food
crops are not only just associated with total
soluble phenolic content but also based on the
composition of phenolic bioactives. Among
detected phenolic acids, higher concentrations
of quercetin was observed in all snap bean
genotypes both under field and greenhouse
conditions. Quercetin is most abundant flavonol
widely distributed in different plant species and
has significant human health benefits (Larson et
al., 2012). Reduction of serum cholesterol and
phospholipid levels was observed in rat with
addition of 1% quercetin in diet (Odbayar et al.,
2006). Similarly, reduction of blood pressure
was also found with quercetin supplementation
in hypertensive subjects (Edwards et al., 2007).
Therefore, higher level of quercetin in snap bean
pods may have significant relevance in
28
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managing macro and micro-vascular risks such
as hypertension and dyslipidemia, which are
commonly associated with T2D. Quercetin,
gallic acid, and catechin are also known as
natural antioxidants and have significant human
health benefits including anti-inflammatory
properties (Saibabu et al., 2015). Antihyperglycemic
and
anti-lipidperoxidative
properties of gallic acid was observed in
diabetic rats (Punithavathi et al., 2011).
Similarly, consumption of catechin rich
beverage has also shown improvement in blood
glucose control in T2D patients (Nagao et al.,
2009). Therefore, the major phenolic acids
found in snap bean genotypes in this study have
potential to contribute to the evaluated
antioxidant and anti-hyperglycemic functions
and can be targeted as functional biomarkers in
therapeutic strategies for management of early
stages of T2D and its associated complications.
CONCLUSION
Legumes such as snap beans are
considered as healthy food choices due to their
diverse bioactive profiles including phenolic
metabolites. However, these phenolic bioactives
and associated health benefits of snap bean vary
widely among different genotypes and due to
growing conditions. Therefore, prior to the
targeted utilization of snap beans in medicinally
relevant therapeutic strategies, it is essential to
screen and evaluate different genotypes and
from different growing conditions for their
optimum phenolic bioactive-linked antihyperglycemic functionality using rapid in vitro
assay models. Overall, moderately high and
relevant TSP content, hig h TA acti vit y and
high α-amylase inhibitory activity were found in
Oregon5630 snap bean genotypes, while high αglucosidase inhibitory activity was observed in
Ebro and Eagle genotypes in this study.
However, significant variations in phenoliclinked antioxidant and anti- hyperglycemic
functionalities were observed in Tendergreen
genotype when compared between field and
greenhouse growing conditions and therefore,
needs further evaluation. However, snap bean

genotypes with moderate phenolic-linked antihyperglycemic functionality can be targeted in
therapeutic
strategies
against
chronic
hyperglycemia and chronic oxidative stress,
commonly associated with early stages T2D.
Further clinical studies with animal models and
wider screening of other snap bean genotypes
for medicinally relevant targeted properties are
required to validate the findings of this in vitro
study and further to advance the use of snap
bean in medicinally relevant therapeutic
intervention strategies targeting early stages of
T2D and associated risks.
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